Aprea Therapeutics
APRE
APRE
66 hedge funds and large institutions have $50.3M invested in Aprea Therapeutics in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 13 closing their positions.
Holders
66
Holders Change
+2
Holders Change %
+3.13%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
15
Increased
25
Reduced
16
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$2.33M |
| 2 |
2
BlackRock
New York
|
$4.08M |
| 3 |
3
Artisan Partners
Milwaukee,
Wisconsin
|
$2.55M |
| 4 |
CCM
4
CAAS Capital Management
New York
|
$906K |
| 5 |
5
Two Sigma Investments
New York
|
$781K |
